Schroder Investment Management Group’s AstraZeneca AZN Stock Holding History

Schroder Investment Management Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-317	Closed	-$74K	–	1357
2021 Q4	$74K	Sell	317 -350	-52%	-$41.2K	﹤0.01%	1317
2021 Q3	$160K	Buy	667 +269	+68%	+$31.3K	﹤0.01%	1358
2021 Q2	$48K	Buy	+398	New	+$43.7K	﹤0.01%	1446
2019 Q1	–	Sell	-400	Closed	-$30K	–	1168
2018 Q4	$30K	Hold	400	–	–	﹤0.01%	1191
2018 Q3	$32K	Sell	400 -107	-21%	-$8.09K	﹤0.01%	1223
2018 Q2	$35K	Buy	507 +23	+5%	+$1.66K	﹤0.01%	1246
2018 Q1	$34K	Buy	+484	New	+$33.5K	﹤0.01%	1245
2014 Q4	–	Sell	-241	Closed	-$17.2K	–	1346
2014 Q3	$17.2K	Hold	241	–	–	﹤0.01%	1348
2014 Q2	$17.9K	Sell	241 -14,242	-98%	-$1.03M	﹤0.01%	1314
2014 Q1	$940K	Buy	14,483 +601	+4%	+$38.8K	﹤0.01%	981
2013 Q4	$824K	Sell	13,882 -179	-1%	-$9.72K	﹤0.01%	1055
2013 Q3	$730K	Buy	+14,061	New	+$706K	﹤0.01%	1053

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Schroder Investment Management Group's AZN Position: Q1 2022 in Review

Schroder Investment Management Group sold out of AstraZeneca (AZN) in Q1 2022, closing a stake of 317 shares — an estimated $74K sold.

Schroder Investment Management Group first reported a position in AZN in Q3 2013 and held it in 12 quarters. The position peaked at $940K in Q1 2014. 982 funds tracked by Wall St. Rank hold AZN as of Q1 2022.

Schroder Investment Management Group reported no remaining AstraZeneca position as of Q1 2022 after selling out during the quarter.
Schroder Investment Management Group sold 317 AstraZeneca shares in Q1 2022, an estimated $74K.
Schroder Investment Management Group first reported a position in AstraZeneca in Q3 2013 and held it in 12 quarters.
Schroder Investment Management Group's AstraZeneca position peaked at $940K in Q1 2014.
982 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2022.

Based on Schroder Investment Management Group's 13F filing for Q1 2022, filed 16 May 2022.